Selegiline and mortality in subjects with Parkinson's disease: a longitudinal community study.
Ben-Shlomo
Y
Y
Lees
A
A
D000978:Antiparkinson Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D006801:Humans; D008137:Longitudinal Studies; D010300:Parkinson Disease / Q000188:drug therapy* / Q000401:mortality*; D012642:Selegiline / Q000009:adverse effects* / Q000627:therapeutic use*
D000978:Antiparkinson Agents; D012642:Selegiline